Literature DB >> 18523403

Prevalence of goiter among children aged 11-16 years in Ahwaz, Iran.

Seyed Mehdi Monajemzadeh1, Ali Zamani Moghadam.   

Abstract

OBJECTIVE: This cross-sectional study was conducted in Ahwaz, Iran to find out the prevalence of goiter among schoolchildren ages 11-16 years. SUBJECTS AND METHODS: Multistage sampling methodology was followed for selecting the study population. A total of 1,950 children (1,050 males, 900 females) were clinically assessed for thyroid gland enlargement. Data were collected on age, sex, weight, height, iodized salt consumption, family history of goiter, and thyroid size by palpation.
RESULTS: One hundred forty-six of the 1,950 children showed various grades of goiter, giving a prevalence of overall goiter of 7.48%. Of the 146 persons with goiter, 46 (31.5%) were male and 100 (68.5%) were female. Prevalence of goiter among male and female students was 4.4 and 11.1%, respectively. Prevalence of grade 1, 2, and 3 goiters was 56.8% (83 cases), 37.7% (55 cases), and 5.5% (8 cases), respectively. A significant difference existed between height of students with grade 1 goiter and those with grade 2 and 3 goiter (p < 0.001). A significant difference also was found between weight of students with grade 1 goiter and students with grade 2 goiters (p < 0.002).
CONCLUSION: These results indicate that Ahwaz City is not an endemic area for iodine deficiency, probably because of its geographic location (the low altitude of sea level) or nutritional habits of its population (consumption of fish and iodized salt). (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523403     DOI: 10.1159/000129615

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  1 in total

1.  Thiocyanate status does not play a role in the etiology of residual goiter in school children of Isfahan, Iran.

Authors:  Ammar H Keshteli; Mahin Hashemipour; Mansour Siavash; Masoud Amini
Journal:  World J Pediatr       Date:  2010-11-16       Impact factor: 2.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.